Effect of humic acids on lead poisoning in bones and on a subcellular level in mitochondria.
Vaskova JankaLadislav VaškoPavol MudroňMartin HausDaniel ŽatkoKlára KrempaskáMarek StupákPublished in: Environmental science and pollution research international (2020)
Humic acids (HA) are natural substances which exhibit a remarkable spectrum of health benefits, such as their role in chelation. This study aims to supplement the current knowledge on the chelating effects of HA in chronic lead intoxication in rat femurs and in liver, heart and kidney mitochondria in an experiment lasting 10 weeks. Lead acetate trihydrate was administered to rats for 5 weeks at a daily dose of 155.5 mg/kg body weight. At the same time, rats were given three concentrations of HA, with their effect measured over the following 5 weeks. Increased Pb concentrations were detected in the femur after the first week, while HA-administered groups showed a tendency towards inhibiting the increase in Pb deposition. After 5 weeks, Pb concentrations dropped significantly in the HA groups. At the same time, however, other elements were redistributed, with a decrease in Se and Zn being particularly noteworthy. While an increase in Pb concentrations was found after 5 weeks of Pb administration, a concentration of 1% HA resulted in the least significant increase in Pb as well as an increase/decrease in Se/Cu, respectively. In mitochondria, an increase in Pb content was detected after the first and fifth weeks with concomitant redistribution of other elements. At the end of the experiment, again in the 1% HA group, Pb concentrations remained higher only in the liver with the other elements sufficiently normalized, indicating this concentration to be useful in the treatment of Pb intoxication.
Keyphrases
- heavy metals
- aqueous solution
- gestational age
- body weight
- healthcare
- risk assessment
- mental health
- heart failure
- public health
- randomized controlled trial
- physical activity
- oxidative stress
- climate change
- preterm birth
- drinking water
- endoplasmic reticulum
- combination therapy
- postmenopausal women
- bone mineral density
- placebo controlled